Mohammad R. Masjedizadeh

3 Patents

• US123369992025

  Modified Release Formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl) Pyrazolo[3,4-d] Pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl) Piperazin-1-yl]pent-2-enenitrile

  Principia Biopharma Inc.

  0 cites
• US122811202025

  Crystalline Forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile

  Principia Biopharma Inc.

  0 cites
• US118722292024

  Modified Release Formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

  Principia Biopharma Inc.

  0 cites